Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatic Enzyme Supplementation for Celiac Disease Symptoms
NCT02475369Phase 4Terminated
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- May 2015
- Primary completion
- Jun 2019
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Pancreaze in celiac disease, sponsored by Beth Israel Deaconess Medical Center. Started May 2015; status: terminated.
02
Drugs
Pancreaze
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT02475369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02475369.